Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 8
Submit an article Journal homepage
19
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Determination of Plasma Cell Secreting Potential as an Index of Maturity of Myelomatous Cells and a Strong Prognostic Factor

A. Symeonidis Hematology Division, Department of Internal Medicine, University of Patras Medical School, P.O. Box 1045, 261.10, Patras, Greece
,
A. Kouraklis-Symeonidis Hematology Division, Department of Internal Medicine, University of Patras Medical School, P.O. Box 1045, 261.10, Patras, Greece
,
E. Grouzi Hematology Division, Department of Internal Medicine, University of Patras Medical School, P.O. Box 1045, 261.10, Patras, Greece
,
V. Zolota Pathology Laboratory, University of Patras Medical School, Patras, Greece
,
M. Melachrinou Pathology Laboratory, University of Patras Medical School, Patras, Greece
,
K. Kourea Pathology Laboratory, University of Patras Medical School, Patras, Greece
,
E. Fragopanagou Hematology Division, Department of Internal Medicine, University of Patras Medical School, P.O. Box 1045, 261.10, Patras, Greece
,
N. Giannakoulas Hematology Division, Department of Internal Medicine, University of Patras Medical School, P.O. Box 1045, 261.10, Patras, Greece
,
U. Seimeni Hematology Division, Department of Internal Medicine, University of Patras Medical School, P.O. Box 1045, 261.10, Patras, Greece
,
M. Tiniakou Hematology Division, Department of Internal Medicine, University of Patras Medical School, P.O. Box 1045, 261.10, Patras, Greece
,
P. Matsouka Hematology Division, Department of Internal Medicine, University of Patras Medical School, P.O. Box 1045, 261.10, Patras, Greece
&
N. Zoumbos Hematology Division, Department of Internal Medicine, University of Patras Medical School, P.O. Box 1045, 261.10, Patras, Greece
 show all
Pages 1605-1612 | Published online: 01 Jul 2009

  • KyIe, R. (1995) "Prognostic factors in multiple myeloma". Stem Cells 13(Suppl. 2), 56-63.
  • Greipp, P., Raymond, N., KyIe, R. and O'Fallon. W.M. (1985) "Multiple myeloma: significance of plasmablastic subtype as a poor prognostic subtype in morphological classification". Blood 65, 305-310.
  • Murakami, H., Kawada, T., Saitoh, T., et al., (1999) "A staging system for multiple myeloma based on the morphology of myeloma cells". Ear. J. Hematol. 62, 63-67.
  • Dimopoulos, M., Barlogie. B., Smith, T. and Alexanian, R. (1991) "High serum lactale dehydrogenase level as a marker for drug resistance and short survival in multiple myeloma". Ann Int. Med. 115,931-935.
  • Bataille, R., Bocadoro, M., Klein. B., Durie, B. and Pileri, A. (1992) "C-Reactive protein and ß2-micmglobulin produce a simple and powerful myeloma staging system". Blood 80, 733-737.
  • Greipp, P., Lust, J., O'Fallon, M., Katzmann, J., Witzig. T. and Kyle. R. (1993) "Plasma cell labeling index and ß2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma". Blood 81, 3382-3387.
  • Merlini, G., Perfetti. V, Gobhi, P.G., et al., (1993) "Acute phase proteins and prognosis in multiple myeloma". Br. J. Haematol. 83, 595-601.
  • Pelliniemi, T.T., Irijala, K., Manila, K., et al., (1995) "lmmunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma. Finnish Leukemia group". Blood 85. 765-771.
  • Kynsonis, M.C., Dedoussis, G., Baxevanis, C. Stamatelou, M. and Maniatis, A. (1996) "Serum interleukin-6 (IL-6) and interleukin-4 (IL-4) in patients with multiple myeloma", Br. J. Haematol. 92. 420-422.
  • Pulkki, K., Pelliniemi, T.T., Rajamaki, A., Tienhaara, A., Laakso. M. and Lahtinen. R. (1996) "Soluble interleukin-6 receptor as a prognostic factor in multiple myeloma. Finnish Leukemia Group". Br. J. Haematol. 92, 370-374.
  • Kaiser, U., Oldenburg, M., Jacques, G., Auerbach. B. and Havemann, K. (1996) "Soluble CD56 (NCAM): a new differential-diagnostic and prognostic marker in multiple myeloma". Ann. Hematot. 73, 121-126.
  • Abildgaard, N., Bentzen, S.M., Nielsen. J.L. and Heickendorff. L. (1997) "Serum markers of bone metabolism in multiple myeloma: prognostic value of the carboxyterminal telopeptide of type I collagen (ICTP). Nordic myeloma study group", Br. J. Haematol 96, 103-110.
  • Turesson, L. Abildgaard, N., Ahlgren, T., et al., (1999) "For the Nordic myeloma study group. Prognostic evaluation in multiple myeloma: on analysis of the impact of new prognostic factors". Br. J. Haematol. 106, 1005-1012.
  • Drach, J., Gattringer, C., Glassl, H., Drach, D and Huber. H. (1992) "The biological and clinical significance of lbe Ki-67 growth traction in multiple myeloma". Haematol Oncol. 10. 125-134.
  • San Miguel. J.F., Garcia-Sanz, R., Gonzalez, M., et al., (1995) "A new staging system for multiple myeloma based on the number of S-phase plasma cells". Blood 85, 448-455.
  • Pellegrini, W., Facchetti, R. Marocolo, D., et al. (1995) "Assessment of cell proliferation in normal and pathological bone marrow biopsies: a study using double sequential immunophenotyping on paraffin sections", Histopathology 27, 397-405.
  • Ocqueteau, M., Orfao, A., Garcia-Sanz. R., Almeida, J., Gonzalez. M. and San Miguel, J.F. (1996) "Expression of the CD117 antigen (c-Kit) on normal and myelomatous plasma cells". Br. J. Haematol. 95,489-493.
  • Mathew, P., Ahmann, G.J., Witzig, T.E., Roche, P.C., KyIe, R. A. and Greipp, RR. (1995) "Clinicopathological correlates of CD56 expression in multiple myeloma: a unique entity?", Br. J. Haematol. 90.459-461.
  • Kawano, MM., Mahmoud, M.S., Huang. N., et at., (1995) "High proportions of VLA-5 (-) immature myeloma cells correlated well with poor response to treatment in multiple myeloma". Br. J. Haematol. 91, 860-864.
  • Pellat-Deceanynck, C., Barilli, S., Pathier, D., et at., (1995) "Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading and immortalization", Cancer Res. 55, 3647-3653.
  • Lai, H., Zantecki, M., Mary. J.Y., et al., (1995) "Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis". Blood 85, 2490-2497.
  • Tricot, G., Barlogie, B., Jagannath, S., et al. (1995) "Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities". Blood 86,4250-4256.
  • Bianchi, A., Mariani, S., Beggiato, E., et al., (1997) "Distribution of T-cell signaling molecules in human myeloma". Br. J. Haematol. 97,815-820.
  • Brown, R.D., Yuen, E., Nelson, M., Gibson, J. and Joshua, D. (1997) "The prognostic significance of T-cell receptor beta gene rearrangements and idiotype-reactive T-cells in multiple myeloma". Leukemia 11, 1312-1317.
  • Stauder, R., van Driel, M., Schwartzier, C., et al., (1996) "Different CD44 splicing patterns define prognostic subgroups in multiple myeloma". Blood 88, 3101-3108.
  • Sailer, M., Vykoupil, K.F., Peest, D., Coldewey, R., Deicher, H. and Georgii, A. (1995) "Prognostic relevance of a histologic classification system applied in bone marrow biopsies from patients with multiple myeloma: a histopathological evaluation of biopsies from 153 untreated patients", Eur. J. Haematol. 54, 137-146.
  • Durie, B.G.M and Salmon, S.E. (1975) "A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival". Cancer 36, 842-852.
  • KyIe, R.A. (1994) "Why better prognostic factors for multiple myeloma are needed", Bloods", 1713-1716.
  • Bettini, R., Tonolini, M. and Bemasconi, M. (1998) "Multiple myeloma index: verification of a new prognostic approach with evaluation of treatment response". Haematologica 83, 708-713.
  • Pasqualetli, P., Collacciani, A., Colantonio, D. and Casalc. R. (1992) "Prognostic value of the plasma cell synthesis score in multiple myeloma". Acta Hematol. 87, 58-62.
  • Weh, HJ., Gutensohn, K., Selbach, J., et al., (1993) "Karyolype in multiple myeloma and plasma cell leukemia". Eur. J. Cancer 29A. 1269-1273.
  • Nowak, R., Oelschlagel. U., Range. U., Molle, M. and Ehninger. G. (1998) "The incidence of DNA aneuploidy in multiple myeloma does not correlate with stage of disease". Am. J. Clin. Pathol. 109. 226-232.
  • Sonneveld, P., Schösier, M. and de Leeuw, K. (1991) "In vitro Igsynthesis and proliferative activity in multiple myeloma are stimulated by different growth factors". Br. J. Haematol. 79, 589-594.
  • Sawamura, M., Murakami, H. and Tsuchiya. J. (1996) "Tumor necrosis factor-alpha and interleukin-4 in myeloma cell precursor differentiation". Lenk. Lymphoma 21, 31-36.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.